In LQTS, the identification of a P/LP variant in KCNQ1, KCNH2, or SCN5A, together with the duration of the corrected QT (QTc) are critical in assessing the risk of life‐threatening arrhythmias in asymptomatic subjects. This evidence concerns the gene KCNH2 and familial long QT syndrome.